View Document Preview and Link Document Date: 2014-04-04 06:29:30 Open Document File Size: 128,77 KB Share Result on Facebook
Company Guideline Development Group / / Country United Kingdom / Wales / / IndustryTerm health services / treatment for high blood pressure / technology appraisal / prevention of cardiovascular disease / / MedicalCondition Vascular disease / hypertension / nonfatal stroke / CHD / disease / peripheral arterial disease / NICE’s prioritisation criteria Cardiovascular disease / fatal and nonfatal myocardial infarction / haemorrhagic stroke / stroke / diabetes / cardiovascular disease / directly employed practice staff 1C Disease / fatal and nonfatal stroke / mortality Cardiovascular disease / ischaemic stroke / coronary heart disease / high blood pressure / / MedicalTreatment Statin therapy / Drug therapy / / Organization National Collaborating Centre / NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK / Primary Care QOF Indicator Advisory Committee / Department of Health / NHS / Advisory Committee / Care Quality Commission / / Product simvastatin / / ProvinceOrState Michigan / / Technology CVD / / SocialTag 
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD